RxDoctor Payments Data

Anthony Spinella, MD

Family Medicine · Sarasota, FLNPI 1235129784

Payments from drug & device makers

$756in general payments, 2019–2025

Across 38 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$199
  • Exact Sciences$88
  • Lilly USA, LLC$76
  • Pfizer$76
  • GSK$72
  • AstraZeneca$51
  • plus $194 from 8 others

What the payments were for

  • Food & beverage$756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$756 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$368,160
Medicare patients
824
Services billed
8,728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban79$80,501
OzempicSemaglutide39$52,037
JardianceEmpagliflozin51$48,467
MounjaroTirzepatide37$35,718
RybelsusSemaglutide22$28,245
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$15,290
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$10,748
Breo ElliptaFluticasone/Vilanterol17$10,529
Atorvastatin Calcium870$6,908
Omeprazole356$4,749
Rosuvastatin Calcium482$4,574
Levothyroxine Sodium429$4,276
Losartan Potassium508$4,158
Pantoprazole Sodium227$3,784
SynthroidLevothyroxine Sodium69$3,686

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$76$80,50179 claims
Novo NordiskOzempic, Rybelsus$199$80,28161 claims
Boehringer IngelheimJardiance$30$48,46751 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$72$36,56750 claims
Lilly USA, LLCMounjaro$76$35,71837 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →